ExCulture
Transforming the production method of life-saving pharmaceuticals
ExCulture has an exclusive licence to a mixed culture fermentation bioprocess technology from TU Delft that they are developing as a novel method for producing heparin-like compounds.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Interview | Bram Kerssemakers - Programme Manager Protein Port
Bram Kerssemakers recently joined the Planet B.io team as Programme Manager Protein Port. He will take responsibility on all activities within Protein Port, a network of companies, institutes and educational institutions aimed at strengthening and accelerating the protein transition. We had a talk with Bram about his career and experience.
Plant One new owner of Bioprocess Pilot Facility at Biotech Campus Delft
Plant One, an established pilot plant company specialized in sustainable production processes, will be the new owner of the Bioprocess Pilot Facility at Biotech Campus Delft. Plant One will further develop the current bioprocess facility into a full-service pilot plant for companies active in biobased and/or biotechnology processes, from SME's to multinationals. The deal was signed at the Biotech Campus Delft earlier today.
Paques Biomaterials | Natural alternatives to plastic
Plastic is everywhere and from its production to its disposal, plastic has a huge impact on our planet. In nature, plastics break down into small particles called microplastics, which accumulate in the food chain. Planet B.io’s resident Paques Biomaterials uses a variety of residual streams to create a biobased and biodegradable alternative to plastic: Caleyda®.